|2010|| Anti-cancer activity of the HIV accessory molecule viral protein R (Vpr): Delivery as a DNA expression plasmid or biologically active peptides.
|2009|| Analysis of the potential for HIV-1 Vpr as an anti-cancer agent.
Current HIV research.
|2008|| Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
|2007|| Enhancement of anti-melanoma activity of a plasmid expressing HIV-1 Vpr delivered through in vivo electroporation.
Cancer biology & therapy.
|2006|| Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
Molecular therapy : the journal of the American Society of Gene Therapy.
|2006|| Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation.
Cancer Gene Therapy.
|2003|| Electroporation as a method for the efficient in vivo delivery of therapeutic genes.
DNA and cell biology.